Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    Transplantation and cellular therapy · 2024
    FCFranco Castillo TokumoriZCZhengming ChenSASebastian A. MayerTBTsiporah B Shore+4 more →AGAlexandra Gomez Arteaga
    PMID: 39243817DOISenior author1 citations
  2. 2
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2020
    AGAlexandra Gomez ArteagaGSGunjan ShahMSMichael ScordoPBParastoo Bahrami DahiHLHeather Landau+3 more →
    PMID: 32712326PMCID: PMC7609585DOIFirst author2 citations
  3. 3
    Bone marrow transplantation · 2024
    AGAlexandra Gomez Arteaga
    PMID: 39433911DOIFirst author3 citations

Publications

55 publications

Funding

2 grants

Active

1 grant
  • PI
    The National Cord Blood Network, Participating Center
    Cleveland Cord Blood Center · 2024–2025
    CCBC 240041-01
Completed grants (1)
  • Sub-PI
    Multicenter Retrospective Analysis to Study the Impact of Molecular Mutations on Transplant Outcomes in Patients with Myelofibrosis.
    MPN Research Foundation · 2021–2023 · via Memorial Sloan Kettering Cancer Center
    No publications yet
    MSKCC 220930-01

Clinical research

7 studies

Active

1 study
  • PI
    A Phase 2 Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
    PHASE2 · Orca Biosystems · OPEN TO ACCRUAL (as of 2026)
    Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Mixed Phenotype Acute Leukemia
    NCT07216443
Completed & closed trials (6)
  • PI
    Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events
    National Marrow Donor Program · IRB STUDY CLOSURE (as of 2026)
    Acute Myeloid Leukemia in Remission
    NCT05224661
  • PI
    A Phase 1 Study of agenT-797 to Treat Moderate to Severe Acute Respiratory Syndrome in COVID-19 Patients
    PHASE1 · Agenus Inc · IRB STUDY CLOSURE (as of 2025)
    Respiratory Distress Syndrome, Adult
    NCT04582201
  • PI
    Phase II Multicenter Trial of Iberdomide as Maintenance Therapy for Multiple Myeloma Patients With Sub-Optimal Response After Autologous Hematopoietic Cell Transplantation or After Salvage Autologous Hematopoietic Cell Transplantation
    PHASE2 · Memorial Sloan Kettering Cancer Center · IRB STUDY CLOSURE (as of 2025)
    Multiple Myeloma
    NCT05354557
  • PI
    A Phase Ib Trial of Patients With Advanced Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation With Either Orca-T, a T-cell-Depleted Graft With Additional Infusion of Conventional T Cells and Regulatory T Cells, or Standard-of-Care Allogeneic Graft
    PHASE1 · Orca Biosystems · CLOSED TO ACCRUAL (as of 2024)
    Acute Myeloid Leukemia; Acute Lymphoid Leukemia; Myelodysplastic Syndromes; Acute Leukemia; Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN); Chronic Myeloid Leukemia
    NCT04013685
  • PI
    A Prospective Study of Tocilizumab for the Prevention of Graft Failure and Graft-versus-Host Disease in Haplo-Cord Transplantation
    PHASE2 · Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2023)
    Hematologic Malignancy; Bone Marrow Transplant
    NCT04395222
  • PI
    Emergency Use of Posoleucel (ALVR105) for Treatment of Human Herpesvirus 6 Infection in Patient A-S
    Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2023)

Media highlights

1 clip

External relationships

Other

Elsevier, BV